Audrey Greenberg is Co-founder of the Center for Breakthrough Medicines and Discovery Labs where she is responsible for business development, corporate strategy, team attraction and engagement, and joint venture and investor relations. Before launching CBM, Audrey spent two decades working as a private equity executive, investment banker and public accountant. Audrey has an MBA from the Wharton School at the University of Pennsylvania and is a registered CPA in Illinois. Selected as one of the Top Trailblazers in Biotech, Audrey Greenberg has a strong track record of building life science startup companies through capital attraction, strategic relationships, novel technologies, and top-tier management teams. She is a renowned keynote speaker on subjects including DEI initiatives, “Cellicon Valley,” accelerating speed to market for advanced therapies and building bio-innovation hubs. Ms. Greenberg is a champion of women’s leadership causes and mentor to aspiring young professionals. Audrey is a member of the Board of Directors for New York Mortgage Trust (NASDAQ: NYMT), the Greater Philadelphia Chamber of Commerce and the King of Prussia Business District. She is an active participant in the Chamber’s Diverse Procurement Collaborative, Philadelphia Skills Forward Initiative, and the CEO Council for Growth’s Cell and Gene Therapy and Connected Health Initiative. She also serves as a judge for the PACT Enterprise Awards as an Advisor for International Society of Pharmaceutical Engineers.